SCHEMBL13020667

SCHEMBL13020667

CC[C@H]1O[C@@H](C)C(OP(C)OC[C@H]2O[C@@H](C)C(C)C2C)C1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020666 0.82 — —
SCHEMBL13020670 0.74 — —
SCHEMBL10260288 0.73 — —
SCHEMBL13899227 0.73 — —
SCHEMBL19263831 0.73 — —
SCHEMBL35361 0.73 — —
SCHEMBL12300420 0.73 — —
SCHEMBL10260241 0.73 — —
SCHEMBL21214912 0.73 — —
SCHEMBL12746267 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331397-A1 2-5A ANALOGS AND THEIR METHODS OF USE ALIOS BIOPHARMA, INC. (US) 2010-12-30 — — US disclosed
Send feedback